ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 134 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $118,000 | +280.6% | 12,653 | +308.8% | 0.00% | – |
| Q1 2024 | $31,000 | -54.4% | 3,095 | -85.3% | 0.00% | – |
| Q4 2023 | $68,000 | +74.4% | 21,094 | +182.1% | 0.00% | – |
| Q3 2023 | $39,000 | -7.1% | 7,478 | +67.2% | 0.00% | – |
| Q2 2023 | $42,000 | +13.5% | 4,472 | +33.3% | 0.00% | – |
| Q1 2023 | $37,000 | -61.5% | 3,354 | -48.2% | 0.00% | – |
| Q4 2022 | $96,000 | +357.1% | 6,478 | +473.8% | 0.00% | – |
| Q3 2022 | $21,000 | +50.0% | 1,129 | +73.2% | 0.00% | – |
| Q2 2022 | $14,000 | -62.2% | 652 | -65.7% | 0.00% | – |
| Q1 2022 | $37,000 | -65.1% | 1,900 | -62.8% | 0.00% | – |
| Q4 2021 | $106,000 | +68.3% | 5,107 | +93.4% | 0.00% | – |
| Q3 2021 | $63,000 | +12.5% | 2,640 | +28.6% | 0.00% | – |
| Q2 2021 | $56,000 | +51.4% | 2,053 | +59.8% | 0.00% | – |
| Q1 2021 | $37,000 | +311.1% | 1,285 | +297.8% | 0.00% | – |
| Q4 2020 | $9,000 | +800.0% | 323 | +1600.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 19 | +11.8% | 0.00% | – |
| Q2 2020 | $1,000 | -93.8% | 17 | -96.9% | 0.00% | – |
| Q1 2020 | $16,000 | – | 557 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 10,542,790 | $305,003,000 | 24.46% |
| Bain Capital Life Sciences Investors, LLC | 3,979,292 | $115,121,000 | 6.52% |
| Pivotal bioVenture Partners Investment Advisor LLC | 569,041 | $16,462,000 | 5.28% |
| SECTORAL ASSET MANAGEMENT INC | 878,948 | $25,428,000 | 1.93% |
| Omega Fund Management, LLC | 623,836 | $18,048,000 | 1.71% |
| Orbimed Advisors | 6,073,850 | $175,716,000 | 1.64% |
| Altium Capital Management LP | 113,962 | $3,297,000 | 0.92% |
| Vivo Capital, LLC | 744,370 | $21,535,000 | 0.76% |
| Polar Capital Holdings Plc | 1,557,543 | $45,060,000 | 0.28% |
| Birchview Capital, LP | 9,000 | $260,000 | 0.15% |